Aphria Inc (APHA) Receives a Buy from GMP FirstEnergy

By Austin Angelo

In a report released yesterday, Justin Keywood from GMP FirstEnergy maintained a Buy rating on Aphria Inc (APHAResearch Report), with a price target of C$14.00. The company’s shares closed last Monday at $5.43, close to its 52-week low of $3.75.

According to TipRanks.com, Keywood is ranked #4176 out of 5546 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Aphria Inc with a $7.96 average price target, implying a 51.9% upside from current levels. In a report issued on October 14, Seaport Global also maintained a Buy rating on the stock with a $8.00 price target.

See today’s analyst top recommended stocks >>

Based on Aphria Inc’s latest earnings release for the quarter ending May 31, the company reported a quarterly net profit of $11.76 million. In comparison, last year the company had a net profit of $16.33 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Aphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis.